Portfolio 2
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Sep 19, 2022 | Inworld AI | inworld.ai | $577M | United States, California, Livermore |
Mentions in press and media 20
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 1, 2026 | KKR to control South Korea’s $1.3 billion renewables platform with SK as AI power demand rises | KKR will take management control of a new $1.3 billion renewable energy platform in South Korea. The new venture will help South Korea meet the surging demand for clean power from AI data centers and semiconductor production lines. South Ko... |
| Nov 27, 2025 | SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation | New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration SEOUL, South Korea, Nov. 27, 2025 /PRNewswire/ -- SK Bioph... |
| Oct 21, 2025 | SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform | SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 21, 2025 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a b... |
| Oct 31, 2023 | SK Life Science Labs, a Subsidiary of SK Biopharmaceuticals, Presents Discovery of Oral SMARCA2 Degraders Data at 6th Annual Targeted Protein Degradation Summit | Preclinical data show SK Life Science Labs compounds have robust anti-tumor efficacy in vivo and oral leads have demonstrated potent selective degradation of SMARCA2 with selective inhibition of proliferation of SMARCA4 mutant cells KING OF... |
| Oct 13, 2023 | SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics | New data presented on novel orally bioavailable p300-selective degraders showing significant anti-tumor activity in preclinical models of androgen receptor (AR) positive prostate cancer SEOUL, South Korea and KING OF PRUSSIA, Pa., Oct. 13, ... |
| Jun 21, 2023 | VFC acquires Meatless Farm brand: ‘Our immediate priority is to get much-loved products back on the market’ | UK-based alt meat brand VFC (Vegan Fried Chick*n) has acquired distressed meat-free brand Meatless Farm, which laid off most of its staff earlier this month after a key investor expected to provide a capital injection backed out. Under the ... |
| Jun 12, 2023 | Brief: Meatless Farm exec: ‘The business has unfortunately made all the teams redundant’ | Loss-making UK-based plant-based meat startup Meatless Farm has laid off most of its employees after failing to secure additional funds to help it stay afloat, according to messages posted by former team members on LinkedIn. One of multiple... |
| Mar 16, 2023 | SK Inc. to bolster its investment in future mobility in the fast growing Southeast Asian market | SOCAR Mobility Malaysia, majority owned by SK Inc., to expand its market dominance in Southeast Asia as SK Inc. integrates business know-how acquired from the US market SK Inc. sees its return on investment double from its investment in Tur... |
| Mar 16, 2023 | SK Inc. to bolster its investment in future mobility in the fast growing Southeast Asian market | SOCAR Mobility Malaysia, majority owned by SK Inc., to expand its market dominance in Southeast Asia as SK Inc. integrates business know-how acquired from the US market SK Inc. sees its return on investment double from its investment in Tur... |
Show more
Reviews 0
FAQ about SK Inc
How many startups has SK Inc invested in?
SK Inc has 2 portfolio companies on Parsers VC, among them Inworld AI.
What has the press written about SK Inc?
Parsers VC has collected 20 articles mentioning SK Inc, among them “KKR to control South Korea’s $1.3 billion renewables platform with SK as AI power demand rises” (Jul 1, 2026) and “SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation” (Nov 27, 2025).
Is SK Inc still active?
Yes, SK Inc is active; its latest activity on Parsers VC dates from Oct 14, 2026.